secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2025-03-18T23:59:59+00:00
Accession:  0001753926-25-000467
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella completes final close of Series B offering ($88.5K) and launches March warrant offering
--------------------------------------------------------------------------------

- Final close sold 885 shares of Series B preferred at $100/share for $88,500 gross; net proceeds $73,455.
- Warrant offering: up to 60,000 warrants at $0.125 each, each exercisable for 1 Series B share ($100) convertible at $2.16.
- Placement agent Spartan receives $15,045 fees, 10,326 Series C preferred shares, and warrants for 4,060 common shares.
- Registration rights require filing within 30 days; failure triggers 100,000 common shares or cash penalty monthly.
- Proceeds from both offerings intended for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392625000467/0001753926-25-000467-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392625000467/g084733_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-25-000467

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer